ES2071227T3 - Composicion para gotas para los ojos. - Google Patents
Composicion para gotas para los ojos.Info
- Publication number
- ES2071227T3 ES2071227T3 ES91307275T ES91307275T ES2071227T3 ES 2071227 T3 ES2071227 T3 ES 2071227T3 ES 91307275 T ES91307275 T ES 91307275T ES 91307275 T ES91307275 T ES 91307275T ES 2071227 T3 ES2071227 T3 ES 2071227T3
- Authority
- ES
- Spain
- Prior art keywords
- composition
- eye drops
- benzoxadine
- thioxo
- cyclodextrin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Ophthalmology & Optometry (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
SE DESCRIBE UNA COMPOSICION DE GOTAS PARA LOS OJOS QUE CONTIENEN COMO COMPONENTE PRINCIPAL EFECTIVO UN ACIDO 3, 4-DIHIDRO-2, 8-DIISOPROPIL3-TIOXO-2H-1, 4-BENZOXADINA-4-ACETICO O UNA SAL SUYA FARMACEUTICAMENTE ACEPTABLE Y CICLODEXTRINA.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP21482790 | 1990-08-13 | ||
JP16285491 | 1991-07-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2071227T3 true ES2071227T3 (es) | 1995-06-16 |
Family
ID=26488494
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES91307275T Expired - Lifetime ES2071227T3 (es) | 1990-08-13 | 1991-08-08 | Composicion para gotas para los ojos. |
Country Status (16)
Country | Link |
---|---|
US (1) | US5663170A (es) |
EP (1) | EP0472327B1 (es) |
JP (1) | JP2769253B2 (es) |
KR (1) | KR920003971A (es) |
AT (1) | ATE121295T1 (es) |
AU (1) | AU633754B2 (es) |
CA (1) | CA2048942A1 (es) |
DE (1) | DE69109021T2 (es) |
DK (1) | DK0472327T3 (es) |
ES (1) | ES2071227T3 (es) |
FI (1) | FI97777C (es) |
HU (1) | HU207950B (es) |
NO (1) | NO177845C (es) |
PT (1) | PT98643B (es) |
RU (1) | RU2068260C1 (es) |
TW (1) | TW200402B (es) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993018764A2 (en) * | 1992-03-18 | 1993-09-30 | Coopervision Pharmaceuticals, Inc. | VERAPAMIL HCl FORMULATION AND OTHER OPHTHALMIC SOLUTIONS WITH BUFFER SYSTEM FOR OCULAR ADMINISTRATION |
US5472954A (en) * | 1992-07-14 | 1995-12-05 | Cyclops H.F. | Cyclodextrin complexation |
US5324718A (en) * | 1992-07-14 | 1994-06-28 | Thorsteinn Loftsson | Cyclodextrin/drug complexation |
WO1994010976A1 (en) * | 1992-11-16 | 1994-05-26 | Ciba Vision Ag, Hettlingen | Polyvinyl alcohol/borate ophthalmic drug delivery system |
US5494901A (en) * | 1993-01-05 | 1996-02-27 | Javitt; Jonathan C. | Topical compositions for the eye comprising a β-cyclodextrin derivative and a therapeutic agent |
SE501482C2 (sv) * | 1993-06-24 | 1995-02-27 | Leiras Oy | Komposition för topisk administration av bispilokarpinsyradiestrar till ögat i form av en vattenlösning |
WO1995003784A1 (en) * | 1993-07-28 | 1995-02-09 | Insite Vision Incorporated | Suspensions for delivery of medicament |
US5631297A (en) * | 1994-07-11 | 1997-05-20 | Pate; David W. | Anandamides useful for the treatment of intraocular hypertension, ophthalmic compositions containing the same and methods of use of the same |
CA2192965C (en) * | 1994-07-11 | 2007-12-04 | David W. Pate | Anandamide analogue compositions and method of treating intraocular hypertension using same |
JP3297969B2 (ja) * | 1994-12-26 | 2002-07-02 | ライオン株式会社 | 点眼剤 |
KR100261585B1 (ko) * | 1995-01-20 | 2000-07-15 | 오쿠다 기요아키 | 항염증점안제 |
ATE215821T1 (de) * | 1995-01-20 | 2002-04-15 | Wakamoto Pharma Co Ltd | Entzündungshemmende augentropfen |
US6476004B1 (en) | 1996-07-18 | 2002-11-05 | Mitsubishi Pharma Corporation | Pharmaceutical composition |
JPH11209277A (ja) * | 1998-01-19 | 1999-08-03 | Yoshitomi Pharmaceut Ind Ltd | 医薬組成物 |
JP2002241272A (ja) * | 1996-07-18 | 2002-08-28 | Mitsubishi Pharma Corp | 医薬処方組成物 |
GB9711643D0 (en) * | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
WO2000012137A1 (en) * | 1998-09-02 | 2000-03-09 | Allergan Sales, Inc. | Preserved cyclodextrin-containing compositions |
JP2001125052A (ja) * | 1999-10-25 | 2001-05-11 | Lion Corp | コンタクトレンズ装着液 |
ES2263623T3 (es) * | 2000-06-19 | 2006-12-16 | Santen Pharmaceutical Co., Ltd. | Agentes antisepticos. |
US6468989B1 (en) | 2000-07-13 | 2002-10-22 | Dow Pharmaceutical Sciences | Gel compositions containing metronidazole |
US6881726B2 (en) | 2001-12-24 | 2005-04-19 | Dow Pharmaceutical Sciences | Aqueous compositions containing metronidazole |
JPWO2006137433A1 (ja) * | 2005-06-21 | 2009-01-22 | わかもと製薬株式会社 | レボカバスチンを可溶化させた水性薬剤 |
US20100069335A1 (en) * | 2005-07-15 | 2010-03-18 | Rajiv Bhushan | Prevention and Treatment of Ophthalmic Complications of Diabetes |
MY169816A (en) | 2012-03-26 | 2019-05-16 | Santen Pharmaceutical Co Ltd | Ophthalmic solution comprising diquafosol |
CN112272578A (zh) * | 2018-04-27 | 2021-01-26 | 阿勒根公司 | 抗微生物功效增强且毒性降低的亚氯酸钠组合物 |
CN114746079A (zh) * | 2019-11-21 | 2022-07-12 | 三进制药株式会社 | 用于预防或治疗眼部疾病的滴眼剂组合物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU602641B2 (en) * | 1986-04-17 | 1990-10-18 | Senju Pharmaceutical Co., Ltd. | Thiolactam-N-acetic acid derivatives, their production and use |
-
1991
- 1991-07-29 TW TW080105889A patent/TW200402B/zh active
- 1991-08-05 JP JP3195186A patent/JP2769253B2/ja not_active Expired - Lifetime
- 1991-08-08 EP EP91307275A patent/EP0472327B1/en not_active Expired - Lifetime
- 1991-08-08 AU AU81708/91A patent/AU633754B2/en not_active Ceased
- 1991-08-08 DE DE69109021T patent/DE69109021T2/de not_active Expired - Fee Related
- 1991-08-08 AT AT91307275T patent/ATE121295T1/de active
- 1991-08-08 ES ES91307275T patent/ES2071227T3/es not_active Expired - Lifetime
- 1991-08-08 DK DK91307275.7T patent/DK0472327T3/da active
- 1991-08-12 FI FI913811A patent/FI97777C/fi not_active IP Right Cessation
- 1991-08-12 RU SU915001489A patent/RU2068260C1/ru active
- 1991-08-12 CA CA002048942A patent/CA2048942A1/en not_active Abandoned
- 1991-08-12 PT PT98643A patent/PT98643B/pt not_active IP Right Cessation
- 1991-08-12 NO NO913136A patent/NO177845C/no unknown
- 1991-08-13 KR KR1019910013973A patent/KR920003971A/ko not_active Application Discontinuation
- 1991-08-13 HU HU912692A patent/HU207950B/hu not_active IP Right Cessation
-
1992
- 1992-07-13 US US07/912,580 patent/US5663170A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5663170A (en) | 1997-09-02 |
FI913811A0 (fi) | 1991-08-12 |
ATE121295T1 (de) | 1995-05-15 |
TW200402B (es) | 1993-02-21 |
FI913811A (fi) | 1992-02-14 |
EP0472327B1 (en) | 1995-04-19 |
NO913136L (no) | 1992-02-14 |
DE69109021T2 (de) | 1995-09-21 |
DK0472327T3 (da) | 1995-05-08 |
PT98643B (pt) | 1999-01-29 |
EP0472327A1 (en) | 1992-02-26 |
FI97777B (fi) | 1996-11-15 |
DE69109021D1 (de) | 1995-05-24 |
HU207950B (en) | 1993-07-28 |
FI97777C (fi) | 1997-02-25 |
JP2769253B2 (ja) | 1998-06-25 |
JPH05213757A (ja) | 1993-08-24 |
HU912692D0 (en) | 1992-01-28 |
NO177845B (no) | 1995-08-28 |
PT98643A (pt) | 1992-07-31 |
AU633754B2 (en) | 1993-02-04 |
NO177845C (no) | 1995-12-06 |
KR920003971A (ko) | 1992-03-27 |
AU8170891A (en) | 1992-02-20 |
HUT61196A (en) | 1992-12-28 |
NO913136D0 (no) | 1991-08-12 |
CA2048942A1 (en) | 1992-02-14 |
RU2068260C1 (ru) | 1996-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2071227T3 (es) | Composicion para gotas para los ojos. | |
DE69010139D1 (de) | Haarkräftigungsmittel. | |
ES2115733T3 (es) | Composicion antialergica para uso oftalmico o nasal. | |
NO912630D0 (no) | Fremgangsmaate for fremstilling av nye 2,6-dialkyl-4-silyl-fenoler. | |
ATE179173T1 (de) | 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy 1,3-propandiol-derivate | |
DE69121211D1 (de) | Applanationstonometer | |
FI911131A (fi) | Menetelmä viherkaihia estävien 3-aryylikarbonyyli-1-aminoalkyyli-1H-indoliyhdisteiden valmistamiseksi | |
ES2127181T3 (es) | 11-beta-aril-gona-4,9-dien-3-onas. | |
PT99503A (pt) | Processo para a preparacao de novos derivados da n-benzoil-prolina e de composicoes farmaceuticas que os contem | |
BR9200627A (pt) | Processo para a preparacao de um composto e composto obtido | |
DK0458589T3 (da) | Behandling af okulær hypertension med en okulær synergistisk kombination | |
DE69122555T2 (de) | 2,4-Dihydroxyadipinsäurederivate | |
DE69023459D1 (de) | Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten. | |
PT84750B (pt) | Processo de preparacao de uma composicao para o envenenamento de roedores, a base de derivados de 1,4-naftoquinona | |
DK0775692T3 (da) | Guanidinomethylcyclohexancarboxylsyreesterderivater | |
DK81890A (da) | 2-hydrozy-n,n,n-trimethylethanaminiumsalte af 5 beta-cholan-24-syrederivater | |
BR8801794A (pt) | Composicao fungicida e processo para a preparacao de derivados de 2-(o-alquila/substituido/)-2-tio-1,3,2-oxatiofosfolano | |
DE3578172D1 (de) | 2,5-pyrrolidindion-derivate mit antiarrhythmischer wirkung. | |
IT9021262A1 (it) | Derivati 1, 4-benzotiacinici ad attivita' calcio antagonista | |
MX9203096A (es) | Derivados de n-(2'-aminofenil)-benzamida, proceso para la preparacion de la misma y composiciones farmaceuticas que los contienen. | |
ES1014307Y (es) | Pieza de ojete para calzados. | |
BR8902385A (pt) | Politioureias,processo para a preparacao das mesmas | |
NO924046D0 (no) | 2[, 3[-dideoksy-4[-tioribonukleosider som antivirusmidler |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 472327 Country of ref document: ES |